Ozempic , Wegovy, Mounjaro , and Zepbound, although all used for weight management, differ in their mechanisms of action, dosage forms, and potential side effects
It is not recommended for those under 18, pregnant or breastfeeding women, or individuals with medical conditions who have not consulted a doctor
This might also lead to alteration in the doses of other concomitant anti-diabetic agents prescribed
The choice between berberine and GLP-1 medications depends on your health goals, existing health conditions, and the magnitude of weight loss you seek
You can learn more about safety considerations in this IV therapy safety guide
It is fully FDA-approved and commercially available under two distinct brand names depending on its clinical indication: Mounjaro: Approved for the treatment of type 2 diabetes to improve glycemic control